• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 1.95% Nasdaq Down 2.40%

    bluebird bio, Inc. (BLUE)

    -NasdaqGS
    159.27 Jun 29, 4:00PM EDT
    |Pre-Market : 160.50 Up 1.23 (0.77%) 8:49AM EDT - Nasdaq Real Time Price
    Add to Portfolio
    Prev Close:159.27
    Open:N/A
    Bid:160.50 x 100
    Ask:162.53 x 600
    1y Target Est:218.14
    Beta:0.386
    Earnings Date:Aug 10 - Aug 14 (Est.)
    Day's Range:N/A - N/A
    52wk Range:29.73 - 197.35
    Volume:1,748
    Avg Vol (3m):901,517
    Market Cap:5.68B
    P/E (ttm):N/A
    EPS (ttm):-2.19
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    BLUE 0.00%5.68B
    BMRN21.21B
    GSK101.50B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):205.61
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-3.16
    Quarterly EPS Est (Jun-15) :-0.79
    Mean Recommendation*:1.8
    PEG Ratio (5 yr expected):-0.25

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    bluebird bio, Inc., a clinical-stage biotechnology company, focuses on developing transformative gene therapies for severe genetic and rare diseases. Its advanced product candidate is Lenti-D, which is in phase II/III clinical studies for the trea... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback